![These highlights do not include all the information needed to use SITAVIG safely and effectively. See full prescribing information for SITAVIG. SITAVIG (acyclovir) buccal tablets Initial U.S. Approval: 1982 These highlights do not include all the information needed to use SITAVIG safely and effectively. See full prescribing information for SITAVIG. SITAVIG (acyclovir) buccal tablets Initial U.S. Approval: 1982](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=sitavig-06.jpg&id=483902)
These highlights do not include all the information needed to use SITAVIG safely and effectively. See full prescribing information for SITAVIG. SITAVIG (acyclovir) buccal tablets Initial U.S. Approval: 1982
![PDF) Efficacy and Safety of Aciclovir Mucoadhesive Buccal Tablet in Immunocompetent Patients With Labial Herpes (LIP Trial): A Double-Blind, Placebo-Controlled, Self-Initiated Trial PDF) Efficacy and Safety of Aciclovir Mucoadhesive Buccal Tablet in Immunocompetent Patients With Labial Herpes (LIP Trial): A Double-Blind, Placebo-Controlled, Self-Initiated Trial](https://i1.rgstatic.net/publication/263778740_Efficacy_and_Safety_of_Aciclovir_Mucoadhesive_Buccal_Tablet_in_Immunocompetent_Patients_With_Labial_Herpes_LIP_Trial_A_Double-Blind_Placebo-Controlled_Self-Initiated_Trial/links/5f996521458515b7cfa41f68/largepreview.png)
PDF) Efficacy and Safety of Aciclovir Mucoadhesive Buccal Tablet in Immunocompetent Patients With Labial Herpes (LIP Trial): A Double-Blind, Placebo-Controlled, Self-Initiated Trial
![Current status and future of delivery systems for prevention and treatment of infections in the oral cavity | SpringerLink Current status and future of delivery systems for prevention and treatment of infections in the oral cavity | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13346-021-00961-2/MediaObjects/13346_2021_961_Figa_HTML.png)